Phase 4 Chronic Kidney Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You must be an adult (over 18 years old) of any gender, race, or ethnicity
- You must be able to understand the study information and give your written consent to participate
- You must have received your first or second kidney transplant at least 3 months ago
- If you have Type 2 diabetes or diabetes that developed after your transplant, your kidney function test results must fall within a specific range, and you may also qualify if you have higher kidney function but protein in your urine (confirm with trial site)
- If you do not have Type 2 diabetes or post-transplant diabetes, your kidney function test results must fall within a slightly different specific range, or you may qualify if you have higher kidney function but protein in your urine (confirm with trial site)
Who may not be able to join:
- You are unwilling or unable to give written consent or follow the study plan
- You have had a pancreas transplant in the past
- Your kidney function is below a certain level, or your kidney function has been declining rapidly over the past year
- You have Type 2 diabetes that is very poorly controlled, with a recent blood sugar average (A1C) above 12%
- You have had more than 2 urinary tract infections (UTIs) in the past year, a UTI that required a hospital stay in the last year, or a serious blood infection from a UTI in the last year
- You have taken a type of diabetes medication called an SGLT2 inhibitor in the last 90 days
- You have a known allergy to SGLT2 inhibitor medications
- You have Type 1 diabetes
- You have a history of a serious complication called diabetic ketoacidosis
- You have a permanent urinary catheter or a surgically rerouted urinary system
- You have had a kidney transplant rejection episode in the last 3 months
- You have had a serious heart event (such as a heart attack or stroke) within the last 3 months
- You have severe heart failure (confirm with trial site)
- You currently have an active fungal skin infection in the groin or genital area
- You have had an amputation due to poor circulation or diabetic foot wounds in the past year
- You have had a cancer diagnosis (other than certain minor skin cancers) within the last 2 years
- You currently have an active serious infection, such as tuberculosis or a fungal, viral, or bacterial infection
- You are living with HIV, even if it is well managed with medication
- You have had an active Hepatitis B infection detected by a blood test within the last 6 months
- You have Hepatitis C and have not shown a sustained clear result (no virus detected) for more than 12 weeks after treatment
- You are currently pregnant
- The study doctor believes there is another reason that joining the study would not be appropriate for you (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Roslyn B Mannon, MD, Omaha VA Nebraska-Western Iowa Health Care System, Omaha, NE
Phone: (205) 999-7362
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Discontinuation of Empagliflozin
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.